Healthcare and
Life Sciences
Sector Lawyers
Legal strategies for growth in healthcare and life sciences.
We support businesses that have an intergenerational impact on the health of communities worldwide. We navigate the legal landscape, so you can focus on shaping the future of your healthcare and life sciences products, service delivery and scientific research.
From negotiating hospital contracts to securing investment for biotechnology breakthroughs, to real estate development, we are one of the preferred advisors for large healthcare and life sciences businesses.
"The AG team is a leader in healthcare and life sciences. They have real strategic focus and strength in depth."
- Legal500
400+
2500+
TIER 1
1250+
clients
matters
ranked
of our matters
in healthcare and life sciences businesses trust us to advise them every year.
have been completed by the healthcare and life sciences team in the last three years.
in Chambers & Partners for Cécile Burgess’ outstanding work in Life Sciences: Product Liability.
in healthcare and life sciences the past three years involved finance, construction, or corporate issues.
400+
2500+
clients
matters
in healthcare and life sciences businesses trust us to advise them every year.
have been completed by the healthcare and life sciences team in the last three years.
TIER 1
1250+
ranked
of our matters
in Chambers & Partners for Cécile Burgess’ outstanding work in Life Sciences: Product Liability.
in healthcare and life sciences the past three years involved finance, construction, or corporate issues.
Strategic legal support for healthcare and life sciences.
We align closely with your business goals. Our expert team advises on the full spectrum of healthcare law, seamlessly integrating support across financing arrangements, M&A, and corporate structuring. Whether you’re navigating private equity investment in biotech or restructuring a healthcare provider group, we ensure regulatory compliance while protecting commercial value.
We also provide comprehensive counsel on competition law, product safety, and procurement strategy, which are key to entering and operating in complex health markets. Our team advises on public and private sector tendering, cross-border trade compliance, and IP protection for medical technologies and pharmaceuticals. From patent licensing to regulatory exclusivity, we help clients safeguard innovation and maintain a competitive edge.
- Share via
- Healthcare
-
National Health Service (NHS)

We are approved to provide consistent legal advice to the NHS and other public sector organisations. The framework was created to ensure consistency regarding legal services through political and economic changes. Find out more about the framework here.
ICBs
Lorem IpsumIndependent Hospitals
Lorem IpsumPrimary Care
Lorem IpsumMedical Insurance
Lorem Ipsum - Social Care
-
Lorem Ipsum
Investors
Lorem IpsumDevelopers
Lorem IpsumOperators
Lorem Ipsum - Life Sciences
-
Lorem Ipsum
Pharma and Biotechnology
Lorem IpsumMedical Devices and Diagnostics
Lorem IpsumHealth Technology
Lorem Ipsum - Healthcare and Life Sciences Finance and Growth?
-
Insert sections around:
Consumer Healthcare
Construction
Finance
??
Our work
Our work
Business transformation in health sector leads to sales of hundreds of pharmacies
A proposed sale of an embedded company in the NHS went under an extensive due diligence process, as a result of the sale the deal revived the business' growth and provided the NHS with much needed funding.
Access the case studyOur work
Our work
Commercial Healthcare: advising on the largest London IPO of 2024
We supported Applied Nutrition, a leading health and wellness brand, in its £350 million IPO which would be the largest consumer offering in the UK since 2021. Explore our strategic legal counsel for high-growth health sector businesses.
Access the case studyOur work
Our work
Public healthcare legal tech case study: From months to 45 minutes
We leveraged advanced AI to swiftly process extensive healthcare data, enabling a timely and compliant response to the UK’s COVID-19 Inquiry. Discover our innovative approach to navigating complex public health challenges.
News and Insights
Featured insight
Hot Topics: Life Sciences - October 2025
News
AG advises Qufora on acquisition of UK business Rapidcare
Featured insight
Hot Topics: Life Sciences August 2025
News
AG advises on sale of New Victoria Hospital to Bupa
News
Addleshaw Goddard advises Phoenix Equity Partners on strategic investment in FutureMeds
Featured insight
Hot Topics: Life Sciences July 2025
Events
Public healthcare legal tech case study
News
Addleshaw Goddard advises Santévet Group and Columna Capital on strategic UK acquisition of Pet Insurer, Tedaisy
Featured insight
EU AI Act facing an uncertain future
Events
EU AI Act - Healthcare & Life Sciences Briefing
Featured insight
UK Publishes 10 Year Infrastructure Strategy
Featured insight
Tech disputes update: ICO fines 23andMe
News
AG advises Tawoos Group on Strategic Acquisition of NMC Oman
News
AG advises RIW Group on acquisition of promedi
Events
Healthcare Spring Drinks
Key Contacts
United Kingdom
Edinburgh
United Kingdom
Dublin, Ireland
Madrid, Spain
UAE & Saudi Arabia
London
Leeds, UK
United Kingdom